期刊文献+

卡培他滨联合铂类同步放化疗方案治疗晚期直肠癌临床研究

Clinical study of capecitabine combined with platinum for concurrent radiotherapy and chemotherapy in the treatment of advanced rectal cancer
下载PDF
导出
摘要 目的:探讨卡培他滨联合铂类同步放化疗方案治疗晚期直肠癌临床效果及安全性。方法:选取晚期直肠癌患者共100例,以随机区组法分为对照组(50例)和试验组(50例),分别在同步放疗基础上加用卡培他滨单药化疗和与奥沙利铂联用化疗;比较两组患者临床疗效、生活质量改善率及不良反应发生率等。结果:试验组患者临床疗效和生活质量改善率显著高于对照组(P<0.05);试验组患者消化道反应和骨髓抑制发生率显著低于对照组(P<0.05);试验组患者手足综合征发生率显著高于对照组(P<0.05)。结论:卡培他滨联合铂类同步放化疗方案治疗晚期直肠癌可有效延缓病情进展,提高生活质量,并有助于降低消化道和骨髓抑制不良反应。 Objective:To investigate the clinical effects and safety of capecitabine combined with platinum for concurrent radiotherapy and chemotherapy in the treatment of advanced rectal cancer.Methods:lO0 patients with advanced rectal cancer were chosen and randomly divided into two groups including control group (50 patients) with eapecitabine used alone and treatment group (50 patients) with capecitabine combined with platinum for concurrent radiotherapy and chemotherapy; and the clinical effects, the improvement rate of quality of life and the incidence of adverse reactions of both groups were compared.Results:The clinical effects and the improvement rate of quality of life of treatment group after treatment was significant better than control group ( P〈0.05 ) .The incidence of digestive tract reaction and bone marrow suppression of treatment group after treatment was significant lower than control group ( P〈0.05 ) .The incidence of hand foot syndrome of treatment group after treatment was significant higher than control group ( P〈 0.05 ) .Conclusion:Capecitabine combined with platinum for concurrent radiotherapy and chemotherapy in the treatment of advanced rectal cancer can efficiently delay the disease progress, higher the quality of life and be helpfl to reduce the risk of digestive tract and bone marrow suppression.
机构地区 解放军第
出处 《安徽卫生职业技术学院学报》 2016年第6期29-30,共2页 Journal of Anhui Health Vocational & Technical College
关键词 卡培他滨 铂类 放化疗 晚期直肠癌 Capecitabine Platinum Radiotherapy and chemotherapy Advanced rectal cancer
  • 相关文献

参考文献4

二级参考文献46

  • 1Taylan Kav,Yusuf Bayraktar.How useful is rectal endosonography in the staging of rectal cancer?[J].World Journal of Gastroenterology,2010,16(6):691-697. 被引量:34
  • 2金晶,李晔雄,刘跃平,王维虎,李涛,李宁,宋永文.Ⅱ期和(或)Ⅲ期直肠癌术后希罗达同步放化疗的研究[J].中华肿瘤杂志,2006,28(5):393-396. 被引量:26
  • 3Fisher B,Wolmark N.Reckettte H.et al.Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer:results from NSAPB Protocol R-01.J Natl cancer Inst,1988,80:21-29.
  • 4孙燕,石远凯.临床肿瘤内科学.5版.北京:人民卫生出版社,2008:500.
  • 5Pacelli F,Di-Giorgio A,Papa V,et al.Preoperative radiotherapy combined with intraopemtive radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer.Dis Colon Rectum,2004,47:170-179.
  • 6Bosset JF,Calais G,Daban A,et al.Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients:assessment of acute toxicity and trealment compliance.Report of the 22921 randomized trial conduced hy the EORTC Radiotherapy Group.Eur J Cancer,2004,40:219-224.
  • 7NCCN Clinical Practice Guideline in Oncology (NCCN Guidelines) Rectal Cancer Version 4.2013[DB/OL][2014-01-25].http://www.nccn.org/professionals/physician_ gls/f_guidelines.asp.
  • 8Park JH,Yoon SM,Yu CS,et al.Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer[J].Cancer,2011,117:3703-3712.
  • 9Roh MS,Colangelo LH,O' Connell MJ,et al.Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum:NSABP R-03[J].J Clin Oncol,2009,27:5124-5130.
  • 10Sauer R,Becker H,Hohenberger W,et al.Preoperative versus postoperative chemoradiotherapy for rectal cancer[J].N Engl J Med,2004,351:1731-1740.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部